Atlas Trials

Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

Clinical trial NCT00788294 · COMPLETED

Trial details

NCT number
NCT00788294
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2008-11-01
Primary completion
2009-06-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.